Developing a Digital Handover Application for Paramedics to Provide a Personalized Approach to Pre-hospital Stratification for Out of Hospital Cardiac Arrest

Out of Hospital Cardiac Arrest Clinical Trial

— RAPID-MIRACLE  

Official title:

Developing a Digital Handover Application for Paramedics to Provide a Personalized Approach to Pre-hospital Stratification for Out of Hospital Cardiac Arrest

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05185063
• Other study ID #: 301864
• Status: Not yet recruiting
• Start date: March 1, 2022
• Est. completion date: March 1, 2024

Study information

• Verified date: December 2021
• Source: King's College London
• Contact: Nilesh Pareek, MA,MRCP,PhD
• Phone: 02032999000
• Email: nileshpareek[@]nhs.net
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A prospective study validating the role of the MIRACLE2 score in patients with resuscitated out of hospital cardiac arrest in a pre-hospital setting.

Description:

Design: Prospective observational cohort study enrolling OOHCA patients across London in a pre-hospital setting

Study Protocol: Patients with OOHCA and ROSC will be recruited from the community into the study by London Ambulance Service NHS Trust (LAS). LAS has -40 Advanced Paramedic Practitioners in Critical Care (APP-CC) who have a range of specialist skills including airway management and focused ultrasound and attend to over 1500 OOHCAs/year.

Point of Care pH test: The recruited participants will have point of care pH testing performed using the CG4+ iStat system (Abbott Vascular, Illinois, U.S.A.). The test requires 2ml of venous blood and can provide blood results within minutes. The device and blood taking system have received CE marking and are already in routine use across the NHS. Once the blood results are received, the blood sample and testing system are discarded in a routine manner.

Standard Care: Participants will then be conveyed to either the local emergency department or to a HAC based on current routine protocols. Patients will be treated in a routine manner after reaching secondary care in accordance with local and national guidance with no change in care based on this study.

Power calculation: In 2019, APP-CCs from LAS attended to -700 OOHCA patients with ROSC. Assuming 60% recruitment, we could comfortably envisage -500 patients to be recruited in a 15 month period. From previous data, we can expect approximately 60% of the patients (n=300) to have a CPC score of 3-5 on hospital discharge. This would be of a similar size to the dataset used to derive the original score, which gave good levels of accuracy in model performance measures.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: March 1, 2024
• Est. primary completion date: June 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with out of hospital cardiac arrest with sustained ROSC (defined as >20 minutes or sufficient stability to consider conveyance)

Exclusion Criteria:

• Any clear non-cardiac cause of arrest (trauma, drowning Overdose, asphyxia, asthma, anaphylaxis).

• Suspected or confirmed intra-cerebral bleeding

• Known CPC score 3 or 4 pre-cardiac arrest

• Known disease limiting survival to 6 months

• Suspected or known pregnancy

Related Conditions & MeSH terms

• Heart Arrest
• Out of Hospital Cardiac Arrest
• Out-of-Hospital Cardiac Arrest

Intervention

Diagnostic Test:
• Point of Care blood test
The pH will be incorporated into the MIRACLE2 score in a pre-hospital setting. The patients will continue to be treated with standard of care.

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
King's College London	King's College Hospital NHS Trust, London Ambulance Service NHS Trust

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cerebral Performance Category at 30 days	Cerebral Performance Category	40 dats
Secondary	All cause mortality at 30 days	Death from any cause	30 days
Secondary	Cause of Death at 30 days	Cause of death defined as neurological,multi-organ dysfunction syndrome, cardiac or unrelated	30 days
Secondary	Cerebral Performance Category at 6 months	Cerebral Performance Category	6 months
Secondary	All cause mortality at 6 months	Death from any cause	6 months
Secondary	Cause of Death at 6 months	Cause of death defined as neurological,multi-organ dysfunction syndrome, cardiac or unrelated	6 months

External Links

•   Heart Research United Kingdom - Novel Emerging Technology Grant